Options for biochemical production of 4‐hydroxybutyrate and its lactone as a substitute for petrochemical production
Abstract Options are discussed for biochemical production of 4‐hydroxybutyrate (4‐HB) and its lactone, gamma‐butyrolactone (GBL), from renewable sources. In the first part of the study, the thermodynamic feasibility of four potential metabolic pathways from glucose to 4‐HB are analyzed. The calculat...
| Published in: | Biotechnology and Bioengineering |
|---|---|
| Main Authors: | , , |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
Wiley
2007
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1002/bit.21709 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbit.21709 https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.21709 |
| Summary: | Abstract Options are discussed for biochemical production of 4‐hydroxybutyrate (4‐HB) and its lactone, gamma‐butyrolactone (GBL), from renewable sources. In the first part of the study, the thermodynamic feasibility of four potential metabolic pathways from glucose to 4‐HB are analyzed. The calculations reveal that when the pathways are NAD + dependent the intermediate succinate semialdehyde (SSA) accumulates leading to low 4‐HB yields at equilibrium. For NADP + dependent pathways the calculated yield of 4‐HB improves, up to almost 100%. In the second part of this study, continuous removal of 4‐HB from the solution is considered to shift SSA conversion into 4‐HB so that SSA accumulation is minimized. One option is the enzymatic production of GBL from 4‐HB. Candida antarctica Lipase B shows good lactonization rates at pH 4, but unfortunately this conversion cannot be performed in‐vivo during 4‐HB production because of the neutral intracellular pH. Biotechnol. Bioeng. 2008;99: 1392–1406. © 2007 Wiley Periodicals, Inc. |
|---|